Podcast Episodes

Back to Search
Ep. 399 - Key themes from Jefferies. Plus: U.K. regulatory innovation
Ep. 399 - Key themes from Jefferies. Plus: U.K. regulatory innovation

Season 7 Episode 399

Speed to patients and cross-border collaboration dominated conversations at London Life Sciences Week, even as investors on both sides of the Atlanti…

1 day, 6 hours ago

Short Long
View Episode
Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton Odds
Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton Odds

Season 7 Episode 398

J&J will pay $2.2 billion upfront to acquire Ollin, a Texas-based NewCo with China-sourced assets, gaining a late-stage VEGF x Ang2 bispecific for we…

4 days, 22 hours ago

Short Long
View Episode
Ep. 397 - What the U.S. midterms mean for biopharma
Ep. 397 - What the U.S. midterms mean for biopharma

Season 7 Episode 397

Midterm election results in the U.S. have short-circuited plans to install a Senate-confirmed FDA commissioner and could open a narrow path to bipart…

1 week, 4 days ago

Short Long
View Episode
Ep. 396 - China’s first-order innovation
Ep. 396 - China’s first-order innovation

Season 7 Episode 396

Rising first-in-class innovation, faster IND reviews and deep patient pools are drawing global biotechs to China, even as U.S. outbound investment re…

2 weeks ago

Short Long
View Episode
Ep. 395 - ESMO analysis & Auchincloss proposal
Ep. 395 - ESMO analysis & Auchincloss proposal

Season 7 Episode 395

A BioCentury analysis of ESMO first-in-human abstracts finds antibody-drug conjugates outnumbering every other modality, even as payload innovation l…

2 weeks, 4 days ago

Short Long
View Episode
Ep. 394 - Security concerns in U.S., China reshaping biotech
Ep. 394 - Security concerns in U.S., China reshaping biotech

Season 7 Episode 394

Proposed U.S. Treasury rules implementing the COINS Act would bar U.S. equity investments, joint ventures and co-development deals with China biotech…

3 weeks, 4 days ago

Short Long
View Episode
Ep. 393 - China trends; Roche, Merck KGaA deals; Arrowhead & tau
Ep. 393 - China trends; Roche, Merck KGaA deals; Arrowhead & tau

Season 7 Episode 393

Roche’s $15 billion biobucks deal with Hansoh for preclinical ADCs is the latest in a string of China licensing deals carrying unusually large upfron…

1 month ago

Short Long
View Episode
Ep. 392 - Biotech markets: Pause before the storm?
Ep. 392 - Biotech markets: Pause before the storm?

Season 7 Episode 392

An M&A-fueled first half gave way to third-quarter underperformance for biotech as a short squeeze in Moderna forced specialist funds into selling so…

1 month, 1 week ago

Short Long
View Episode
Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners

Season 7 Episode 391

Pharma partnering in China is getting earlier and broader, with Merck & Co., Novo Nordisk and Novartis striking multibillion-dollar deals for assets …

1 month, 2 weeks ago

Short Long
View Episode
Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways
Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways

Season 7 Episode 390

Mechanisms broad enough to matter across many diseases, from mitochondrial health to the biology of aging, emerged as a defining theme at Grand Round…

1 month, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us